NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
RADNET INC
NASDAQ:RDNT (1/27/2025, 11:40:39 AM)
63.45
-0.63 (-0.98%)
The current stock price of RDNT is 63.45 USD. In the past month the price decreased by -11.76%. In the past year, price increased by 71.98%.
LOS ANGELES, Jan. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.
USA News Group Commentary Issued on behalf of Avant Technologies Inc. Vancouver, BC – December 17, 2024 – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a critical resource in healthcare, moving beyond its status as a novel concept. With over 800 FDA-cleared AI applications already in […]
/PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc....
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.92 | 83.49B | ||
CVS | CVS HEALTH CORP | 8.79 | 70.24B | ||
LH | LABCORP HOLDINGS INC | 17.33 | 20.90B | ||
DGX | QUEST DIAGNOSTICS INC | 17.99 | 17.75B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.57 | 14.45B | ||
DVA | DAVITA INC | 19.71 | 14.35B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 173.87 | 14.23B | ||
CHE | CHEMED CORP | 24.84 | 8.52B | ||
HIMS | HIMS & HERS HEALTH INC | 69.86 | 6.72B | ||
CRVL | CORVEL CORP | 24.56 | 5.94B | ||
GH | GUARDANT HEALTH INC | N/A | 5.80B | ||
OPCH | OPTION CARE HEALTH INC | 26.22 | 5.31B |
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 7,872 full-time employees. The company went IPO on 2001-12-12. The company has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.
RADNET INC
1510 Cotner Ave
Los Angeles CALIFORNIA 90025 US
CEO: Howard G. Berger
Employees: 7872
Company Website: https://www.radnet.com/
Investor Relations: https://www.radnet.com/about-radnet/investor-relations
Phone: 13104787808
The current stock price of RDNT is 63.45 USD.
The exchange symbol of RADNET INC is RDNT and it is listed on the Nasdaq exchange.
RDNT stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RDNT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RDNT.
RDNT does not pay a dividend.
The PE ratio for RDNT is 113.3. This is based on the reported non-GAAP earnings per share of 0.56 and the current share price of 63.45 USD.
The outstanding short interest for RDNT is 6.07% of its float.
ChartMill assigns a technical rating of 4 / 10 to RDNT. When comparing the yearly performance of all stocks, RDNT is one of the better performing stocks in the market, outperforming 88.15% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to RDNT. RDNT has only an average score on both its financial health and profitability.
Over the last trailing twelve months RDNT reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by 36.59% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.13% | ||
ROE | -0.49% | ||
Debt/Equity | 1.11 |
ChartMill assigns a Buy % Consensus number of 85% to RDNT. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 33.96% and a revenue growth 13.31% for RDNT